Lunit SCOPE Achieves Remarkable Concordance with Pathologists in HER2 Analysis for Advanced Biliary Tract Cancer#South_Korea#Seoul#Lunit#HER2#Biliary_Cancer
Lunit SCOPE Achieves Remarkable Concordance with Pathologists in HER2 Analysis for Advanced Biliary Tract Cancer
A recent study shows Lunit SCOPE's AI technology aligns closely with pathologists in HER2 interpretation, advancing cancer diagnostics for biliary tract cancer.
third-news.com
December 23, 2025 at 2:10 PM
Lunit SCOPE Achieves Remarkable Concordance with Pathologists in HER2 Analysis for Advanced Biliary Tract Cancer#South_Korea#Seoul#Lunit#HER2#Biliary_Cancer
New Study Suggests FOLFIRINOX as a Second-Line Treatment for Advanced Biliary Tract Cancer#South_Korea#Busan#Treatment_Options#Biliary_Cancer#FOLFIRINOX
New Study Suggests FOLFIRINOX as a Second-Line Treatment for Advanced Biliary Tract Cancer
Pusan National University researchers find that the FOLFIRINOX regimen could be a promising second-line chemotherapy option for advanced biliary tract cancer.
third-news.com
November 28, 2025 at 1:50 PM
New Study Suggests FOLFIRINOX as a Second-Line Treatment for Advanced Biliary Tract Cancer#South_Korea#Busan#Treatment_Options#Biliary_Cancer#FOLFIRINOX